Total Funding
10
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Clarassance is a clinical-stage biotechnology company developing secretoglobin-based biopharmaceutical products.
Lisa Beth Ferstenberg: Acting Chief Medical Officer- Aprile Pilon: Founder & CEO
About the Company
Clarassance is a privately-held, clinical-stage Delaware Corporation headquartered in Rockville, Maryland.
Our mission is to develop biopharmaceutical products based on the unique family of proteins called
secretoglobins. There are several secretoglobins made in the human body, the most abundant of which is
called CC10. CC10 is a potent
anti-inflammatory agent that may bring benefit in many types of disease.
Women Founded
Women Led
